Psychedelic Therapy: Complete Guide to Treatments, Options, and How to Find Care

♥ VETTED PSYCHEDELIC THERAPY PROVIDERS

Psychedelic Therapy: Complete Guide to All Treatments in 2026

Psychedelic therapy is no longer fringe medicine. It is the fastest-growing area of psychiatric research globally, backed by Johns Hopkins, NYU, Imperial College London, Stanford, and the FDA itself — which has granted Breakthrough Therapy designation to both psilocybin and MDMA.

For a full picture of what to expect, see the full cost breakdown.

The evidence is now clear: for treatment-resistant depression, PTSD, addiction, end-of-life anxiety, and other conditions that conventional psychiatry has failed to adequately treat, psychedelic medicines offer a new mechanism, a new speed, and outcomes that have surprised even skeptical researchers.

Psychedelic Connect is an advisory that visits every clinic it recommends across all psychedelic modalities. We never charge patients.

Book a Consultation → (866) 435-7057

What Is Psychedelic Therapy?

Psychedelic therapy (also called psychedelic-assisted therapy) involves the supervised, therapeutic administration of psychedelic substances — including psilocybin, MDMA, ketamine, ibogaine, ayahuasca, and 5-MeO-DMT — in structured clinical or retreat settings with trained therapists or guides.

It is not recreational drug use. Psychedelic therapy involves careful pre-treatment medical and psychiatric screening, structured preparation, supervised administration with trained professionals, and integration therapy to process and apply insights.

How Psychedelic Therapy Works: The Shared Mechanism

Despite their differences, psychedelic medicines share core mechanisms that explain their therapeutic effects:

Neuroplasticity: Psychedelics produce measurable increases in neuroplasticity — the brain’s capacity to form new neural connections. Depression, PTSD, and addiction are characterized by rigid, entrenched neural patterns. Neuroplasticity creates a window for change.

Default Mode Network disruption: The default mode network (DMN) governs rumination, self-referential thought, and psychological rigidity. All major psychedelics produce temporary DMN disruption, quieting habitual thought patterns.

Emotional processing: Psychedelics reliably increase emotional openness and reduce defensive avoidance — allowing patients to process traumatic memories and access compassion for themselves.

Meaning-making: A consistent finding across psychedelic research is that participants experience what they describe as “the most meaningful experience of their lives.” This peak-experience quality is statistically correlated with therapeutic outcomes (Griffiths et al., 2016, Johns Hopkins).

Comparison: Which Psychedelic Therapy Is Right for You?

Psychedelic Therapy Modalities

Ibogaine

Ibogaine, derived from the iboga shrub of West Africa, is unparalleled in the treatment of opioid addiction. A single 12–24 hour ibogaine session can eliminate physical withdrawal symptoms, dramatically reduce cravings, and produce the psychological reset necessary for lasting recovery. Available legally in Mexico, Costa Rica, Jamaica, Portugal, and other countries.

Best for: Heroin, fentanyl, opioid prescription addiction; kratom; methamphetamine; cocaine. → Full Ibogaine Guide

Two of the most-compared options are covered in depth in our ibogaine versus ketamine comparison and our ibogaine versus psilocybin comparison.

If you or someone close to you needs help right now, SAMHSA’s national helpline is free, confidential and staffed 24/7 on 1-800-662-HELP.

Where to actually find legal options: psilocybin therapy centres and ketamine clinics near you.

Ketamine

The only psychedelic medicine currently FDA-approved (as esketamine/Spravato) and widely available in US clinics. IV ketamine produces rapid antidepressant effects — often within 24 hours — in patients who have failed multiple conventional medications.

Best for: Treatment-resistant depression, suicidal ideation, PTSD, anxiety. → Full Ketamine Guide

Psilocybin

The active compound in “magic mushrooms,” psilocybin has shown breakthrough results for depression, smoking cessation, alcohol use disorder, and end-of-life anxiety. Legal in Oregon and Colorado (US); internationally in Jamaica, Netherlands, Costa Rica.

Best for: Depression (including treatment-resistant), smoking cessation, alcohol use disorder. → Full Psilocybin Guide

MDMA

MDMA-assisted therapy has produced a 67% PTSD remission rate in Phase 3 clinical trials. FDA approval pending; currently accessible through clinical trials, compassionate use, and Australia.

Best for: Chronic PTSD from any cause, trauma with strong avoidance symptoms. → Full MDMA Therapy Guide

Ayahuasca

An Amazonian brew combining DMT with MAO-inhibiting plants, ayahuasca has centuries of ceremonial use and growing clinical evidence for depression, alcohol addiction, and trauma. Requires careful drug interaction screening (SSRI discontinuation mandatory).

Best for: Depression, trauma, alcohol use disorder. → Full Ayahuasca Guide

5-MeO-DMT

Derived from the Bufo alvarius toad or synthetic sources, 5-MeO-DMT produces a brief (15–45 minute) but extraordinarily intense experience described as complete ego dissolution. Available at clinics in Mexico, Jamaica, and Costa Rica.

Best for: Depression, PTSD, addiction. → 5-MeO-DMT Treatment Guide

How to Choose the Right Psychedelic Therapy

If you have opioid addiction: Ibogaine is the gold standard. Its physical detoxification effect is unique.

If you need treatment in the US legally: Ketamine therapy is your most accessible option. Available in 500+ clinics nationwide.

If you have PTSD: MDMA (through clinical trials or Australia) or ketamine are your best near-term options.

If you have treatment-resistant depression: Ketamine, psilocybin, or MDMA all have strong evidence.

If you want an integrative, ceremonial approach: Ayahuasca retreats or psilocybin retreats in Jamaica or Netherlands.

Call (866) 435-7057 for a consultation → Our team will help you map your options, assess eligibility, and help you find the right provider.

FAQ

Q: Is psychedelic therapy safe? When administered by trained professionals with proper medical screening, psychedelic therapy has a strong safety record. Risks are real but manageable in clinical settings.

Q: Is psychedelic therapy covered by insurance? Esketamine (Spravato) is covered by Medicare and most major insurers for treatment-resistant depression. IV ketamine, psilocybin, MDMA, ayahuasca, and ibogaine are not covered by US insurers.

Q: Do I need to travel internationally for psychedelic therapy? Not necessarily. Ketamine therapy is fully legal in US clinics. Psilocybin is legal in Oregon and Colorado. MDMA is accessible through clinical trials. Ibogaine, ayahuasca, and 5-MeO-DMT currently require international travel.

Q: How is Psychedelic Connect different from a directory? We’re a concierge service, not a list. We have intake conversations with every patient, assess your specific situation and goals, verify provider credentials and safety protocols, and make warm introductions.

See also: Consultation | Ibogaine Safety Guide | Ketamine Therapy | Psilocybin Therapy

Medical disclaimer: Psychedelic Connect is a treatment advisory service. We do not provide medical advice, diagnosis, or treatment recommendations. All psychedelic treatments involve risks. Consult a qualified medical professional before pursuing any treatment.